Inflammation-associated cancer: NF-κB is the lynchpin
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 26 (6) , 318-325
- https://doi.org/10.1016/j.it.2005.04.003
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 SubunitClinical Cancer Research, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Inflammation and cancerNature, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998